Identification of a novel set of genes reflecting different in vivo invasive patterns of human GBM cells

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Monticone, Massimiliano ^a   Daga, Antonio ^a   Candiani, Simona ^b   Romeo, Francesco ^a,c   Mirisola, Valentina ^a   Viaggi, Silvia ^a,b   Melloni, Ilaria ^a   Pedemonte, Simona ^a   Zona, Gianluigi ^a   Giaretti, Walter ^a   Pfeffer, Ulrich ^a   Castagnola, and P ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c TibMolbiol   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DNA; DOUBLE STRANDED DNA; FIBROBLAST GROWTH FACTOR; RECOMBINANT EPIDERMAL GROWTH FACTOR;

ADULT; AGED; ANIMAL CELL; ARTICLE; CANCER INVASION; CELL ADHESION; CELL INFILTRATION; CELL MEMBRANE; CLINICAL ARTICLE; DNA MICROARRAY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION PROFILING; GENE PRODUCT; GENETIC CODE; GENETIC IDENTIFICATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IN VIVO STUDY; MALE; MOUSE; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL; TUMOR GROWTH; XENOGRAFT;

AGED; ANIMALS; BRAIN NEOPLASMS; CHROMOSOME ABERRATIONS; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GLIOBLASTOMA; HUMANS; IMMUNOBLOTTING; MALE; MICE; MICE, INBRED NOD; MICE, SCID; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRINCIPAL COMPONENT ANALYSIS; REPRODUCIBILITY OF RESULTS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 84865054553     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-358     Document Type: Article

References (36)

1. Demuth T, Berens ME. Molecular mechanisms of glioma cell migration and invasion. J Neurooncol 2004, 70(2):217-228. 10.1007/s11060-004-2751-6, 15674479.
2. Silbergeld DL, Chicoine MR. Isolation and characterization of human malignant glioma cells from histologically normal brain. J Neurosurg 1997, 86(3):525-531. 10.3171/jns.1997.86.3.0525, 9046311.
3. D'Abaco GM, Kaye AH. Integrins: molecular determinants of glioma invasion. J Clin Neurosci 2007, 14(11):1041-1048. 10.1016/j.jocn.2007.06.019, 17954373.
4. Harpold HL, Alvord EC, Swanson KR. The evolution of mathematical modeling of glioma proliferation and invasion. J Neuropathol Exp Neurol 2007, 66(1):1-9. 10.1097/nen.0b013e31802d9000, 17204931.
5. Hoelzinger DB, Demuth T, Berens ME. Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment. J Natl Cancer Inst 2007, 99(21):1583-1593. 10.1093/jnci/djm187, 17971532.
6. Giese A, Bjerkvig R, Berens ME, Westphal M. Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol 2003, 21(8):1624-1636. 10.1200/JCO.2003.05.063, 12697889.
7. Nakada M, Nakada S, Demuth T, Tran NL, Hoelzinger DB, Berens ME. Molecular targets of glioma invasion. Cell Mol Life Sci 2007, 64(4):458-478. 10.1007/s00018-007-6342-5, 17260089.
8. Park JB, Kwak HJ, Lee SH. Role of hyaluronan in glioma invasion. Cell Adh Migr 2008, 2(3):202-207. 10.4161/cam.2.3.6320, 2634087, 19262113.
9. Salhia B, Tran NL, Symons M, Winkles JA, Rutka JT, Berens ME. Molecular pathways triggering glioma cell invasion. Expert Rev Mol Diagn 2006, 6(4):613-626. 10.1586/14737159.6.4.613, 16824034.
10. Castriconi R, Daga A, Dondero A, Zona G, Poliani PL, Melotti A, Griffero F, Marubbi D, Spaziante R, Bellora F, et al. NK cells recognize and kill human glioblastoma cells with stem cell-like properties. J Immunol 2009, 182(6):3530-3539. 10.4049/jimmunol.0802845, 19265131.
11. Gangemi RM, Griffero F, Marubbi D, Perera M, Capra MC, Malatesta P, Ravetti GL, Zona GL, Daga A, Corte G. SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity. Stem Cells 2009, 27(1):40-48. 10.1634/stemcells.2008-0493, 18948646.
12. Gary SC, Hockfield S. BEHAB/brevican: an extracellular matrix component associated with invasive glioma. Clin Neurosurg 2000, 47:72-82.
13. Lyons SA, Chung WJ, Weaver AK, Ogunrinu T, Sontheimer H. Autocrine glutamate signaling promotes glioma cell invasion. Cancer Res 2007, 67(19):9463-9471. 10.1158/0008-5472.CAN-07-2034, 2045073, 17909056.
14. Viapiano MS, Hockfield S, Matthews RT. BEHAB/brevican requires ADAMTS-mediated proteolytic cleavage to promote glioma invasion. J Neurooncol 2008, 88(3):261-272. 10.1007/s11060-008-9575-8, 18398576.
15. Griffero F, Daga A, Marubbi D, Capra MC, Melotti A, Pattarozzi A, Gatti M, Bajetto A, Porcile C, Barbieri F, et al. Different response of human glioma tumor-initiating cells to epidermal growth factor receptor kinase inhibitors. J Biol Chem 2009, 284(11):7138-7148. 2652334, 19147502.
16. Monticone M, Biollo E, Fabiano A, Melotti A, Corte G, Fabbi M, Daga A, Romeo F, Maffei M, Giaretti W, et al. Cell Cultures Used in Studies Focused on Targeting Glioblastoma Tumor-Initiating Cells - Response. Molecular Cancer Research 2010, 8(2):291. 2824786, 20145040.
17. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4(2):249-264. 10.1093/biostatistics/4.2.249, 12925520.
18. Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, Braisted J, Klapa M, Currier T, Thiagarajan M, et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 2003, 34(2):374-378.
19. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 2001, 98(9):5116-5121. 10.1073/pnas.091062498, 33173, 11309499.
20. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998, 95(25):14863-14868. 10.1073/pnas.95.25.14863, 24541, 9843981.
21. Telenius H, Pelmear AH, Tunnacliffe A, Carter NP, Behmel A, Ferguson-Smith MA, Nordenskjold M, Pfragner R, Ponder BA. Cytogenetic analysis by chromosome painting using DOP-PCR amplified flow-sorted chromosomes. Genes Chromosomes Cancer 1992, 4(3):257-263. 10.1002/gcc.2870040311, 1382568.
22. Pinkel D, Straume T, Gray JW. Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc Natl Acad Sci U S A 1986, 83(9):2934-2938. 10.1073/pnas.83.9.2934, 323421, 3458254.
23. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010, 17(1):98-110. 10.1016/j.ccr.2009.12.020, 2818769, 20129251.
24. Rebhan M, Chalifa-Caspi V, Prilusky J, Lancet D. GeneCards: integrating information about genes, proteins and diseases. Trends in genetics : TIG 1997, 13(4):163. 10.1016/S0168-9525(97)01103-7, 9097728.
25. Hosack DA, Dennis G, Sherman BT, Lane HC, Lempicki RA. Identifying biological themes within lists of genes with EASE. Genome Biol 2003, 4(10):R70. 10.1186/gb-2003-4-10-r70, 328459, 14519205.
26. Lange K, Kammerer M, Saupe F, Hegi ME, Grotegut S, Fluri E, Orend G. Combined lysophosphatidic acid/platelet-derived growth factor signaling triggers glioma cell migration in a tenascin-C microenvironment. Cancer Res 2008, 68(17):6942-6952. 10.1158/0008-5472.CAN-08-0347, 18757408.
27. Horiguchi H, Hirose T, Sano T, Nagahiro S. Loss of chromosome 10 in glioblastoma: relation to proliferation and angiogenesis. Pathol Int 1999, 49(8):681-686. 10.1046/j.1440-1827.1999.00934.x, 10504534.
28. Tchoghandjian A, Baeza-Kallee N, Beclin C, Metellus P, Colin C, Ducray F, Adelaide J. Rougon G 2011, Cortical and Subventricular Zone Glioblastoma-Derived Stem-Like Cells Display Different Molecular Profiles and Differential In Vitro and In Vivo Properties. Annals of surgical oncology, Figarella-Branger D.
29. Gunther HS, Schmidt NO, Phillips HS, Kemming D, Kharbanda S, Soriano R, Modrusan Z, Meissner H, Westphal M, Lamszus K. Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria. Oncogene 2008, 27(20):2897-2909. 10.1038/sj.onc.1210949, 18037961.
30. Gary SC, Zerillo CA, Chiang VL, Gaw JU, Gray G, Hockfield S. cDNA cloning, chromosomal localization, and expression analysis of human BEHAB/brevican, a brain specific proteoglycan regulated during cortical development and in glioma. Gene 2000, 256(1-2):139-147.
31. Hu B, Kong LL, Matthews RT, Viapiano MS. The proteoglycan brevican binds to fibronectin after proteolytic cleavage and promotes glioma cell motility. J Biol Chem 2008, 283(36):24848-24859. 10.1074/jbc.M801433200, 3259830, 18611854.
32. Matthews RT, Gary SC, Zerillo C, Pratta M, Solomon K, Arner EC, Hockfield S. Brain-enriched hyaluronan binding (BEHAB)/brevican cleavage in a glioma cell line is mediated by a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) family member. J Biol Chem 2000, 275(30):22695-22703. 10.1074/jbc.M909764199, 10801887.
33. Nakada M, Miyamori H, Kita D, Takahashi T, Yamashita J, Sato H, Miura R, Yamaguchi Y, Okada Y. Human glioblastomas overexpress ADAMTS-5 that degrades brevican. Acta Neuropathol 2005, 110(3):239-246. 10.1007/s00401-005-1032-6, 16133547.
34. Viapiano MS, Matthews RT, Hockfield S. A novel membrane-associated glycovariant of BEHAB/brevican is up-regulated during rat brain development and in a rat model of invasive glioma. J Biol Chem 2003, 278(35):33239-33247. 10.1074/jbc.M303480200, 12799382.
35. Joo KM, Kim SY, Jin X, Song SY, Kong DS, Lee JI, Jeon JW, Kim MH, Kang BG, Jung Y, et al. Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas. Laboratory investigation; a journal of technical methods and pathology 2008, 88(8):808-815. 10.1038/labinvest.2008.57, 23024638.
36. Lottaz C, Beier D, Meyer K, Kumar P, Hermann A, Schwarz J, Junker M, Oefner PJ, Bogdahn U, Wischhusen J, et al. Transcriptional profiles of CD133+ and CD133- glioblastoma-derived cancer stem cell lines suggest different cells of origin. Cancer Res 2010, 70(5):2030-2040. 10.1158/0008-5472.CAN-09-1707, 20145155.